Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B ' HIV-1 Candidate Vaccine

File(s)

Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine..pdf (276.14 KB)

Published version

Show more

Author(s)

Vasan, S

Schlesinger, SJ

Huang, Y

Hurley, A

Lombardo, A

more

Type

Journal Article

Date Issued

2010-01-25

Date Acceptance

2009-11-11

Citation

PLOS One, 2010, 5 (1)

URI

http://hdl.handle.net/10044/1/24967

DOI

https://www.dx.doi.org/10.1371/journal.pone.0008617

ISSN

1932-6203

Publisher

Public Library of Science

Journal / Book Title

PLOS One

Volume

5

Issue

1

Copyright Statement

© 2010 Vasan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

License URL

http://creativecommons.org/licenses/by/4.0/

Subjects

Science & Technology

Multidisciplinary Sciences

Science & Technology - Other Topics

MULTIDISCIPLINARY SCIENCES

IMMUNODEFICIENCY-VIRUS TYPE-1

T-CELL RESPONSES

IMMUNITY

PLASMID

PRIME

BOOST

IMMUNIZATION

RECOMBINANT

CHALLENGE

INFECTION

Publication Status

Published

Article Number

ARTN e8617